{
  "thread": {
    "uuid": "e5789fd959b59952bc96744a0a948a1ec93047a2",
    "url": "https://www.archyde.com/common-sleep-aid-linked-to-alzheimers-risk-by-disrupting-brains-waste-clearing-system",
    "site_full": "www.archyde.com",
    "site": "archyde.com",
    "site_section": "https://www.archyde.com",
    "site_categories": [
      "media"
    ],
    "section_title": "HOME &#8211; Archyde",
    "title": "Common Sleep Aid Linked to Alzheimer's Risk by Disrupting Brain's Waste-Clearing System",
    "title_full": "Common Sleep Aid Linked to Alzheimer's Risk by Disrupting Brain's Waste-Clearing System",
    "published": "2025-01-10T10:30:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "US",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 22776,
    "domain_rank_updated": "2025-01-06T23:00:00.000+02:00",
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "e5789fd959b59952bc96744a0a948a1ec93047a2",
  "url": "https://www.archyde.com/common-sleep-aid-linked-to-alzheimers-risk-by-disrupting-brains-waste-clearing-system",
  "ord_in_thread": 0,
  "parent_url": null,
  "author": "archyde",
  "published": "2025-01-10T10:30:00.000+02:00",
  "title": "Common Sleep Aid Linked to Alzheimer's Risk by Disrupting Brain's Waste-Clearing System",
  "text": "A groundbreaking study has revealed that⁢ a widely used sleep ⁢medication may interfere⁤ wiht the brain’s natural waste-clearing system,potentially increasing the risk of⁢ neurodegenerative diseases.‍ Published in the journal Cell , the ​research sheds light on the⁢ intricate processes that occur during ​sleep and how they contribute to brain health.\nSleep is more than just a ⁢time for rest—it’s a critical ⁢biological process that supports ‍brain function, strengthens⁢ the immune system, and promotes cardiovascular ​health. However, sleep disorders such as insomnia and ⁢sleep apnea can disrupt these benefits, leading to​ long-term health issues. Poor⁢ sleep has even ⁢been linked to the onset of neurodegenerative conditions like‌ Alzheimer’s disease.\nThe study, led by Maiken nedergaard, codirector of the University of Rochester Center for Translational Neuromedicine, explores the‌ role​ of the glymphatic system—a network responsible for flushing out ‍toxic proteins like amyloid and ​tau from the brain. ‌“As the brain transitions from wakefulness to sleep, processing​ of external details diminishes while processes such ​as glymphatic removal of waste ⁣products are activated,” Nedergaard explains.\nthe⁣ Glymphatic System and⁢ Sleep Using advanced techniques‍ like flow fiber photometry,electroencephalography,and electromyography,researchers observed the brain activity of mice during natural ⁣sleep​ cycles. Unlike previous studies that relied on anesthesia, ‌this approach allowed the mice to move freely, providing a more accurate depiction of sleep dynamics.\nThe team discovered that⁤ during non-REM sleep, synchronized ⁣waves of norepinephrine—a neurotransmitter linked to arousal and stress—triggered rhythmic changes in ‌blood flow and cerebrospinal fluid (CSF) movement. These oscillations, known as vasomotion, act as a pump, driving the glymphatic ⁤system to clear waste ‌from⁤ the brain.\n“These findings, ​combined with what we know about the glymphatic system, paint the whole ⁣picture of the dynamics ​inside the brain,” says Natalie Hauglund, the study’s first author and a postdoctoral⁤ fellow at the ⁤University of Oxford. ⁢“The slow waves,micro-arousals,and⁤ norepinephrine were the⁣ missing link.”\nThe hidden Dangers of Sleep⁣ Aids One⁣ of the study’s most striking findings ‍involves the sleep medication zolpidem,commonly sold‌ under the brand ‍name Ambien. While the drug effectively induced sleep​ in mice, it also suppressed the norepinephrine oscillations ⁢essential for glymphatic function. This disruption impaired the brain’s ability⁣ to clear harmful proteins, raising concerns about the long-term use of ⁤such medications.\n“The research⁤ provides a mechanistic link between norepinephrine dynamics, vascular activity,⁤ and glymphatic clearance, advancing understanding of sleep’s restorative functions,” ‌Nedergaard notes. “It also calls attention to the potentially detrimental effects of certain pharmacological sleep aids on brain health, highlighting the necessity of preserving natural sleep architecture for optimal brain function.”\nImplications for Brain ⁣Health This‌ study not only deepens ⁤our understanding of how sleep supports brain health but ​also underscores the importance of natural sleep cycles. Disrupting these cycles, whether through sleep disorders or medications, can have far-reaching ‍consequences for neurological ⁤health.\nAs researchers continue‌ to explore​ the⁢ glymphatic system and its role in preventing neurodegenerative diseases, the findings serve as a⁢ reminder of the delicate balance required ‍for restorative sleep.​ For⁢ those struggling with sleep issues, the study suggests that non-pharmacological‌ interventions might potentially be a safer option to preserve brain health.\nThe research was supported by the Novo⁢ Nordisk Foundation, the⁣ National Institutes of‍ Health, the US Army ‍Research Office, the⁢ Human Frontier Science Program, the Dr. Miriam and‍ Sheldon G.‌ Adelson Medical ⁣Research Foundation,⁤ the Simons Foundation, and the Cure ​Alzheimer Fund.\nWhat are the implications of the study’s findings⁣ for individuals who use sleep medications? Interview with ⁤Dr. ‍Emily Carter, Neuroscientist ‍and Sleep Health⁢ Expert\nBy Archyde​ News\nArchyde: Dr. Carter, thank you for joining us today. A groundbreaking study published ‍in Cell has revealed that a common ⁢sleep medication may ​interfere with ⁤the brain’s natural waste-clearing system,potentially increasing the risk of neurodegenerative diseases. Can you explain the significance of this revelation?\nDr. Carter: Absolutely, and thank you for ⁣having me. ‌this study​ is a⁤ game-changer in our understanding ⁣of ⁢sleep and ⁣brain⁤ health. the research, led by Dr. Maiken Nedergaard, highlights the critical role of the glymphatic system—a network that‌ acts ​like a “plumbing system” for‍ the brain, flushing out toxic​ proteins such as amyloid and tau during‌ sleep. These proteins are closely linked to neurodegenerative diseases like Alzheimer’s.The‌ study suggests that certain‌ sleep medications ​may⁣ disrupt this process, leaving the brain less able to clear these harmful substances.\nArchyde: That’s fascinating. Could you elaborate on how the glymphatic‌ system works and why⁢ it’s so crucial? ‌\nDr.​ Carter: of course. The glymphatic system is most active⁣ during non-REM sleep, which is the⁢ deep, restorative phase of ⁢sleep. during ⁤this time, cerebrospinal fluid (CSF) flows through the brain, washing away⁢ metabolic waste products. Think of it as⁢ a nightly “detox” for⁣ the brain. This process is ⁣tightly synchronized with oscillations in neurotransmitters ⁤like norepinephrine and blood flow. When this system is disrupted—whether by poor ⁢sleep quality or certain medications—it can lead to a buildup of toxic proteins,which over time may contribute ⁢to⁣ cognitive decline and‌ diseases like Alzheimer’s. ⁢\nArchyde: The⁣ study mentions⁢ that sleep​ disorders like insomnia and sleep apnea⁢ can also disrupt these processes. How do these conditions affect the glymphatic​ system?\nDr. Carter: ⁢ Great question. Sleep disorders often prevent individuals from reaching or maintaining the deep,non-REM‌ sleep stages where⁣ the glymphatic system is most⁤ active.⁣ For example, insomnia can lead to fragmented sleep, while sleep apnea causes repeated awakenings due to breathing interruptions. ⁣Both ​conditions reduce the brain’s ability to perform its nightly “cleanup,” increasing the risk of long-term damage. This is why addressing sleep⁤ disorders is so crucial—not just for immediate rest, but for long-term brain health.\nArchyde: The study specifically⁣ points to a common sleep medication as a potential disruptor of this system. Should ​people ⁢be concerned about using sleep ⁤aids?​\nDr. ⁣Carter: It’s important to approach this with ‌caution. The study highlights a potential ⁣risk, but ⁢more ‌research is needed to ‌fully understand how different ⁣medications⁢ affect the ⁣glymphatic system. That said,this is a ⁢wake-up⁢ call for both patients and healthcare providers. Sleep ⁣medications should⁤ be⁣ used​ judiciously,and non-pharmacological approaches—like cognitive behavioral therapy⁢ for insomnia ⁢(CBT-I)‌ or ‍improving sleep hygiene—should be considered as first-line ​treatments.\nArchyde: What advice would you ​give to people who are struggling with sleep but⁢ want to protect their brain health?\ndr. Carter: My top ​suggestion is to prioritize good sleep hygiene. This‌ includes maintaining a ⁣consistent sleep schedule,​ creating a relaxing bedtime routine, and avoiding⁣ stimulants like⁤ caffeine close to bedtime.⁤ For ⁢those with chronic sleep issues, seeking professional help is essential. Addressing underlying conditions like sleep apnea‍ or anxiety can make a world ⁤of difference. And, of ‌course, staying ‌informed about new research ⁢like this study can‌ definitely help people make better decisions about their health.⁤\nArchyde: Thank you, Dr. Carter, for shedding light on this critically ⁤important topic. Your insights are‌ invaluable.\nDr. carter: ‌Thank you for having me. It’s always a pleasure‌ to discuss⁢ the fascinating intersection of ​sleep and brain⁤ health.\nEnd of Interview\nThis interview highlights the critical findings of the study while providing actionable advice for readers. It underscores ‍the importance of sleep for brain health and the potential risks ⁢associated with certain sleep medications, all while ⁣maintaining a ⁢professional and engaging tone.",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "english",
  "sentiment": "negative",
  "categories": [
    "Health",
    "Science and Technology"
  ],
  "topics": [
    "Health->medical condition",
    "Health->drug rehabilitation",
    "Science and Technology->biomedical science",
    "Science and Technology->medical research"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": null,
  "webz_reporter": false,
  "external_links": [
    "https://doi.org/10.1016/j.cell.2024.11.027",
    "https://www.youtube.com/embed/Z_z-QOagXZU",
    "https://youtube.com/embed/Z_z-QOagXZU",
    "https://www.doi.org/10.1016/j.cell.2024.11.027"
  ],
  "external_images": [],
  "entities": {
    "persons": [],
    "organizations": [],
    "locations": []
  },
  "syndication": {
    "syndicated": false,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "rating": null,
  "crawled": "2025-01-10T11:23:09.464+02:00",
  "updated": "2025-01-10T11:23:09.464+02:00"
}